Blueprint Medicines
BPMC
$108.55
Share price
2.16%
Change (1 day)
98.45%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Cash on Hand
Cash on Hand as of December 2023 : $0.71 B
According to Blueprint Medicines
's latest financial reports the company has $0.71 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Blueprint Medicines - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.71 B | -24.8% |
| 2022-12-31 | $0.94 B | 98.06% |
| 2021-12-31 | $0.47 B | -45.28% |
| 2020-12-31 | $0.87 B | 80.3% |
| 2019-12-31 | $0.48 B | -2.12% |
| 2018-12-31 | $0.49 B | -26.63% |
| 2017-12-31 | $0.67 B | 214.42% |
| 2016-12-31 | $0.21 B | 31.62% |
| 2015-12-31 | $0.16 B | 244.43% |
| 2014-12-31 | $47.24 M | 2277.45% |
| 2013-12-31 | $1.98 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $0.63 B | -11.15% | 🇺🇸 USA |
 OPKO Health
OPK | $95.88 M | -86.51% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Isoray
ISR | $43.75 M | -93.84% | 🇺🇸 USA |